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Interleukin-12 is an important regulator of other cyto-
kines. Although interleukin-12 is considered to act pri-
marily on lymphocytes, provoking a shift from T
helper 2 to T helper 1 cells and an increase in lympho-
cyte-derived tumor necrosis factor a, we hypothesized
that interleukin-12 might also a¡ect tumor necrosis fac-
tor a secretion from skin cells. In this study, keratino-
cytes were treated with ultraviolet-B, ultraviolet-A, or
sham irradiation, without or with exogenous interleu-
kin-12. Remarkably, the exogenous interleukin-12 to-
tally blocked ultraviolet-B-induced tumor necrosis
factor a production. Both ultraviolet-A and ultraviolet-
B were capable of inducing interleukin-12 production.
To determine the molecular mechanism of this e¡ect,
we used a chloramphenicol acetyl transferase reporter
under the control of a 1.2 kb fragment of the wild-type
(^308G) human tumor necrosis factor a promoter and
found signi¢cant suppression of promoter activity with
interleukin-12. Studies using the ^308A variant of the
human tumor necrosis factor a promoter showed much
higher promoter activity overall, but also a greater sen-
sitivity to suppression by interleukin-12. The mechan-
ism did not involve blockage of the interleukin-1
receptor, because interleukin-12 did not suppress inter-
leukin-1-mediated induction of collagenase mRNA. To
determine the role of endogenous interleukin-12, we
found that anti-interleukin-12 antibodies enhanced ul-
traviolet-B-induced tumor necrosis factor a secretion.
Thus, interleukin-12 strongly inhibits tumor necrosis
factor a production by nonin£ammatory skin cells,
mostly or entirely through inhibition of gene transcrip-
tion via an element within the ¢rst 1.2 kb of the tumor
necrosis factor a promoter.The result is a shift in tumor
necrosis factor a production from nonin£ammatory
cells to T helper 1 cells. Because tumor necrosis factor
a is central to the pathogenesis of several photosensitive
skin diseases and certain forms of immune suppression,
interleukin-12 may have important physiologic, patho-
physiologic, and therapeutic roles. Key words: cytokines/
¢broblasts/lupus/Th1/Th2. J Invest Dermatol 120:116 ^122,
2003
I
nterleukin-12 (IL-12) is an important regulator of other
cytokines. It is a heterodimeric molecule produced primarily
by antigen-presenting cells and plays a key role in promot-
ing T helper 1 (Th1) responses (Adorini, 1999), including
activation of Th1 clones (Kremer et al, 1996). As part of this
shift, IL-12 typically increases the secretion of tumor necrosis fac-
tor a (TNFa), a Th1 cytokine, from in£ammatory cells such as T
cells (Kostense et al, 1998; Nagayama et al, 2000; Ma, 2001). Ultra-
violet-B (UVB) irradiation depresses expression and secretion of
IL-12 from antigen-presenting cells, and UV stimulates lymphoid
organs to secrete the IL-12 p40 homodimer, a natural antagonist
of biologically active IL-12 (Schmitt and Ullrich, 2000). Interest-
ingly, UV-induced immune suppression and tolerance induction
are reversed by recombinant interleukin-12 (Schmitt et al, 1995;
Schwarz et al, 1996). Nearly all studies have examined the role of
IL-12 in altering the immune responses of in£ammatory cells
(DeKruy¡ et al, 1995; Marshall et al, 1995; Matsuo et al, 1996),
although one recent study showed that IL-12 directly suppresses
IL-10 secretion from irradiated keratinocytes and blunts the rise
in plasma TNFa levels that typically occur after UV irradiation
of mice (Schmitt et al, 2000). The latter result cannot be explained
from the fact that IL-12 has stimulatory or neutral e¡ects on TNFa
secretion by immune cells.
UV exerts many medically important e¡ects on the immune
system in susceptible individuals, in part by altering the produc-
tion of speci¢c cytokines, particularly TNFa. For example, con-
tact hypersensitivity that develops on regions of skin painted
with dinitro£uorobenzene is suppressed by prior local cutaneous
irradiation with UVB. To establish a link with TNFa, investiga-
tors have shown that UVB in the presence of autocrine or para-
crine sources of IL-1a induces TNFa production; local
intradermal injection of TNFa impairs the induction of contact
hypersensitivity to dinitro£uorobenzene; and most importantly,
systemic administration of anti-TNFa antibodies abolishes this
immunosuppressive e¡ect of UV exposure (Bromberg et al, 1992;
Yoshikawa et al, 1992; Werth and Zhang, 1999). Mice genetically
de¢cient in TNF-receptor 2 (p75) lack the ability to impair con-
tact hypersensitivity induction after UVB (Kurimoti and Strei-
lein, 1999). Of interest, studies in humans have shown that most
skin cancer patients exposed to UVB and dinitro£uorobenzene
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fail to develop contact hypersensitivity, suggesting a role for
UVB sensitivity in the origin or proliferation of these neoplasms
(Yoshikawa et al, 1990).
UV radiation also plays a substantial role in certain photosensi-
tive autoimmune diseases. Lupus erythematosus (Sullivan et al,
1997), subacute cutaneous lupus erythematosus (Werth et al,
2000), pediatric dermatomyositis (Pachman et al, 2000), and adult
dermatomyositis (Werth et al, 2002) are each associated with the ^
308A polymorphism in theTNFa promoter. This polymorphism
enhances TNFa production, particularly after stimulation with
UVB, consistent with a role in the pathogenesis of photosensitiv-
ity (Werth et al, 2000). The increase in TNFa production after
UVB irradiation is part of a larger set of changes that involve
both nonimmune and immune cells. (Kock et al, 1990; Fujisawa
et al, 1997) UVB also stimulates keratinocytes and ¢broblasts to
secrete IL-1, IL-6, IL-8, IL-10, and IL-15 (Rivas and Ullrich,
1992; Kondo et al, 1993; de Vos et al, 1994; Enk et al, 1995; Grewe
et al, 1995; Mohamadzadeh et al, 1995; Chung et al, 1996; Eberlein-
Konig et al, 1998). Furthermore, studies suggest that UVB radia-
tion generally shifts the immune response in the skin from aTh1
cell response to a Th2 cell predominance, both in terms of the
Th2-associated cytokines produced (IL-4, IL-10) and because of
interference with antigen presentation to Th1 cells (Brown et al,
1995; Ullrich, 1996).We now hypothesize that IL-12 might be an
important inhibitor of TNFa secretion from non-T-cell sources,
and may thereby a¡ect responses of nonimmune cells to UV ir-
radiation. As a model system, we used wavelength-speci¢c stimu-
lation of TNFa secretion from keratinocytes and ¢broblasts
exposed to UVB in the presence of paracrine or exogenous IL-
1a, as previously described (Werth and Zhang, 1999).
MATERIALS AND METHODS
Cultured cells Normal human ¢broblasts were obtained from the
American Type Culture Collection (ATCC, Rockville, MD, Catalog
#1828-CRL). Genotype analysis according to prior methods (Sullivan et
al, 1997) indicated the ^308G (wild-type) TNFa promoter polymorphism.
These cells were grown in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS). Normal neonatal
human keratinocytes were cultured from foreskins and grown in MCDB
153 medium (Sigma, M-7403, St. Louis, MO) supplemented with 30 mM
CaCl2, bovine pituitary extract, epidermal growth factor, insulin,
hydrocorticone, ethanolamine, phosphoethanolamine, high amino acids,
penicillin, and streptomycin. Adult keratinocytes were obtained from
Clonetics (San Diego, CA). Fibroblasts and keratinocytes were plated in
triplicate Petri dishes (60 mm diameter, Corning), and grown to 90%
con£uence before irradiation or cytokine addition.
Light sources and radiometry The UVB source was a bank of two FS-
40 sunlamps (Lights of America,Walnut, CA), with a peak irradiance of 313
nm, equipped with a cellulose triacetate ¢lter to remove wavelengths
below 290 nm, as previously described (Werth and Zhang, 1999). UVB
doses were measured with an International Light UV IL-443 UVB meter.
The ¢ltered UVB light source measured by spectroradiometric
measurement at the time of the experiments showed 0.64% UVC, 44.51%
UVB, 19.43% UVA, and 35.42% visible and near infrared (Vis þ NIR).
The UVA source was a 1000 W xenon lamp solar simulator (Solar Light,
Philadelphia, PA), which was used with a UG5 internal ¢lter and an
external UG11 ¢lter to remove long wavelengths and a 3 mm WG335
Schott (UVA) ¢lter to allow only longer UV wavelengths (Werth and
Zhang, 1999). UVA and UVA1 doses were veri¢ed with an IL 1400 A
Research Radiometer (International Light, Newburyport, MA). The solar
simulator withWG335 Schott ¢lter showed 0.0036% UVC, 0.016% UVB,
96.63% UVA (11.28% UVA2 and 88.72% UVA1), 3.35% Vis þ NIR.
Chemicals Cytokines (IL-1a, IL-12) and cytokine enzyme-linked
immunosorbent assay (ELISA) kits (TNFa, IL-12 p70) were purchased
from Pierce-Endogen (Rockford, Ill.) Anti-IL-12 and anti-interferon-g
(anti-INFg) antibodies were purchased from R&D Systems (Minneapolis,
MN). All other chemicals were obtained from Fisher (Pittsburgh, PA) or
Sigma.
Radiation protocols Radiation doses were 10, 20, and 30 mJ UVB per
cm2, and 5, 10, and 20 J UVA per cm2. Cells receiving sham irradiation
treatment (0 mJ per cm2) went through the same procedure, but covered
with aluminum foil. After irradiation, cells were immediately returned to
DMEM/10% FBS, with or without addition of the following reagents: IL-
1a (10 ng IL-1a per ml) for the ¢broblast experiments, IL-12 (0^10 ng per
ml), anti-g-IFN antibody (1 mg per ml), and anti-IL-12 antibody (10 mg per
ml) for both ¢broblasts and keratinocytes. Conditioned media were
harvested 24 h after irradiation of cells and assayed for either TNFa or IL-
12 levels, using standard ELISA kits (R&D Systems). Three Petri dishes
were used for each irradiation dose. Cytotoxicity of UV was assessed
using trypan-blue staining of cells 24 h after irradiation and was always
o 5%.
Transfection of cultured cells To assess transcriptional activity, we used
two promoter-reporter plasmids, each containing one of the 308
polymorphic forms of the TNFa promoter region (1173 bp) fused to a
chloramphenicol acetyl transferase (CAT) reporter gene, as previously
described (Werth et al, 2000). The wild-type construct contains a G at
position ^308 (^308G), and the variant construct was made by
introducing an A at position ^308 (^308A) by site-directed mutagenesis,
to ensure an otherwise identical promoter sequence. In addition, a
promoterless CAT construct was used to assess assay background. Each
CAT construct was spliced into a pSV vector (Promega, Madison,WI). A
b-gal construct (Promega), driven by SV40 promoter, was spliced into the
same pSV vector to be used as a marker for transfection e⁄ciency.
Murine ¢broblast-like 3T3 cells (N.T.H., Bethesda, MD) and
keratinocyte cells were cultured at 371C for approximately 24 h to 60%^
70% con£uence, followed by transfection. Transfections were done using
FuGENE 6 Transfection Reagent (Boehringer Mannheim, Indianapolis,
IN). After transfection, cells were incubated in complete medium for
24 h. Cultured cells were then placed in phosphate-bu¡ered saline (PBS),
maintained at 351C^371C in a thermostatically controlled water bath, and
irradiated at a distance of 40 cm with the Petri dish cover removed, using
the same irradiation protocols as described above.
CATassay Cells were harvested 24 h after irradiation and extracted with
lysis bu¡er (CAT assay kit, Boehringer Mannheim). CAT and b-gal were
quantitated by ELISA (Boehringer Mannheim), and CAT results were
normalized to b-gal.
Assessment of collagenase mRNA As a control for IL-1a action, we
assessed collagenase mRNA levels by northern blot, as previously
described (Werth et al, 1997).
Statistical analysis Comparisons of several groups simultaneously were
performed by initially using analysis of variance (anova).When the anova
indicated di¡erences amongst the groups, pairwise comparisons of each
experimental group versus the control group were performed using the
Dunnett q0 statistic. Unless otherwise indicated, summary statistics are
reported as means7SEM, n¼ 3. Absent error bars in graphical displays of
summary statistics indicate SEM values smaller than the drawn symbols.
RESULTS
IL-12 blocks TNFa production from UV-irradiated
keratinocytes and ¢broblasts As we previously reported
(Werth and Zhang, 1999), UVB but not UVA stimulated the
secretion of TNFa from cultured neonatal keratinocytes (Fig 1a).
Addition of exogenous IL-12 (10 ng per ml) immediately after
UVB irradiation, however, completely blocked TNFa release
from these cells (Fig 1a). Similarly, addition of IL-12 to cultured
¢broblasts stimulated with UVB, exogenous IL-1a, or the
combination reduced TNFa secretion to undetectable levels (Fig
1b). Addition of di¡erent concentrations of IL-12 to adult
keratinocytes after UVB irradiation showed inhibition of TNFa
secretion beginning at a dose of 50 pg per ml, with progressively
greater inhibition thereafter (Fig 1c). This result con¢rms our
underlying hypothesis, proving that IL-12 strongly inhibits
TNFa secretion from these nonimmune cells. This is in contrast
to immune cells, where IL-12 has stimulatory or neutral e¡ects
on TNFa production (Kostense et al, 1998; Nagayama et al, 2000;
Ma, 2001).
Because UVB, but not UVA, stimulates the secretion of TNFa
by keratinocytes and ¢broblasts (Werth and Zhang, 1999), and
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because IL-12 is a strong inhibitor of TNFa secretion (Fig 1), we
next determined if there might be wavelength-speci¢c induc-
tion of IL-12 secretion. Instead, we found that UVB and UVA
each signi¢cantly induced secretion of the active IL-12 p70
heterodimer, in a dose-responsive fashion (Fig 2). This induction
of IL-12 release raised the possibility that endogenously secreted
IL-12 might regulate cellular output of TNFa. Thus, we
examined TNFa secretion in the absence or presence of anti-IL-
12 antibodies. TNFa levels from adult keratinocytes increased to
2.5 of the control value in the presence of UVB þ anti-IL-12
antibodies relative to UVB alone (Fig 3a). Levels of TNFa seen
in these experiments with adult keratinocytes (Figs 1c, 3a) were
higher than those seen with neonatal keratinocytes (Fig 1a), but
IL-12 consistently suppressed TNFa output from both cell types.
In similar experiments with ¢broblasts,TNFa increased 4-fold in
the presence of UVB þ IL-1a þ anti-IL-12 antibodies relative
to UVB þ IL-1a alone (Fig 3b). Nevertheless, addition of anti-
IL-12 antibodies to keratinocytes irradiated with UVA (5 J per
cm2) had no e¡ect on TNFa secretion (Fig 3a). Anti-IL-12
antibodies added to UVA-irradiated, IL-1a-treated ¢broblasts
failed to induce any detectable TNFa secretion (data not shown).
These results indicate that the amount of autocrine or paracrine
IL-12 produced by these cells after UVB irradiation is su⁄cient
to partially suppress TNFa production, but that the inability of
UVA to induce TNFa release by keratinocytes and ¢broblasts is
unrelated to endogenous IL-12.
Lack of role for IFNc or IL-1a signaling in the suppression
of UVB-induced TNFa production by IL-12 IFNg is
stimulated by IL-12 and mediates some IL-12 e¡ects (Seder et al,
1993). Nevertheless, we found that anti-g-IFN antibodies had no
e¡ect on IL-12 suppression of TNFa (data not shown).
Induction of TNFa secretion by UVB is substantially
enhanced in the presence of IL-1a, which keratinocytes secrete
but which has to be provided exogenously to ¢broblasts (Werth
and Zhang, 1999). Thus, it is possible that IL-12 could suppress
TNFa release by inhibiting IL-1a signaling. To explore this
possibility, we examined collagenase mRNA, which is induced
by IL-1a and by TNFa. Fibroblasts exposed to IL-1a (Fig 4,
lane 2) showed increased collagenase mRNA relative to
unirradiated, untreated sham cells (Fig 4, lane 1). Addition of
500 pg IL-12 per ml and IL-1a (Fig 4, lane 3) gave collagenase
mRNA levels similar to IL-1a in the presence of anti-TNFa
antibodies and IL-1a (Fig 4, lane 4). Anti-TNFa antibodies
blocked some of the collagenase upregulation in UV-irradiated
cells, but left IL-1a-mediated induction intact (data not shown).
This result demonstrates that IL-12 does not block IL-1a-
mediated upregulation of collagenase mRNA, suggesting that
IL-12 is a¡ecting TNFa secretion independent of e¡ects on IL-
1a or its receptor.
IL-12 inhibits TNFa promoter activity To evaluate the
molecular mechanism for IL-12-induced suppression of TNFa
release, we transiently transfected twoTNFa promoter constructs
(^308G wild-type and ^308A variant) into human adult
keratinocytes and mouse 3T3 ¢broblasts. The transfected cells
Figure1. IL-12 inhibits UVB-induced TNFa production by cell
(a) IL-12 inhibits UVB-induced neonatal keratinocyte TNFa production.
Neonatal keratinocytes were irradiated with 30 mJ per cm2 of UVB, 5 J per
cm2 of UVA, or sham irradiated, and then given media without (minus sym-
bols) or with (plus symbols) 10 ng IL-12 per ml, followed by 24 h of incuba-
tion at 371C. Displayed areTNFa concentrations in the conditioned media.
The TNF ELISA is sensitive to o 2 pg per ml. (b) IL-12 inhibits UVB-
induced ¢broblast TNFa production. Fibroblasts were irradiated with 30
mJ per cm2 of UVB, or sham irradiated, and then given media without
(minus symbols) or with (plus symbols) 10 ng IL-1a per ml, 10 ng IL-12 per
ml, followed by 24 h of incubation at 371C. Displayed are TNFa concen-
trations in the conditioned media. (c) IL-12 inhibits UVB-induced adult
keratinocyte TNFa production in a dose-dependent manner. Adult kerati-
nocytes were irradiated with 30 mJ per cm2 of UVB, 5 J per cm2 of UVA,
or sham irradiated, and then given media with 0^5000 pg IL-12 per ml,
followed by 24 h of incubation at 371C. Displayed are TNFa concentra-
tions in the conditioned media.
118 WERTH ETAL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
were irradiated with UVB (30 mJ per cm2) or sham,7IL-12, and
in the case of 3T3 cells, 7IL-1a . In transfected keratinocytes,
UVB irradiation increased the activity of both TNFa promoter
constructs, but ^308A was 3.5 times more active than ^308G
(Fig 5a), consistent with our prior results (Werth et al, 2000).
Addition of IL-12 (500 pg per ml) inhibited UVB-induced
promoter activity by 55% (^308G) and 85%
(^308 A; Fig 5a). In the transfected 3T3 ¢broblasts, UVB in
combination with IL-1a produced large increases in CAT
activity relative to IL-1a alone, UVB alone, or untreated cells,
and the ^308 A construct was again substantially more active
than ^308G (compare Fig 5b, c). Addition of IL-12 produced
large suppressions of both promoter constructs under nearly all
conditions examined (Fig 5b, c). These results indicate that IL-12
acts on the TNFa promoter, on an element within the ¢rst
1173 bp.
DISCUSSION
We have shown here that exogenous IL-12 blocks UVB-induced
TNFa secretion by keratinocytes and ¢broblasts. Furthermore,
through addition of anti-IL-12 antibodies (Fig 3), we have found
large regulatory e¡ects of endogenous IL-12 on TNFa secretion
in the absence of exogenously added IL-12.The increase in TNFa
secretion seen upon addition of anti-IL-12 antibodies to irradiated
keratinocytes and ¢broblasts (Fig 3) also suggests that induction
of endogenous IL-12 occurs prior toTNFa release. Many lines of
evidence indicate that keratinocyte- or ¢broblast-derived TNFa
participates in UV-induced skin diseases (Werth et al, 2000; 2002),
and our new results suggest that these processes can be controlled
by exogenous or endogenous IL-12.
Prior literature and these studies provide some clues about the
molecular mechanisms by which exogenous and endogenous IL-
12 inhibits TNFa production. IL-12 was previously found to in-
hibit gene transcription and release of IL-10 from UVB-irra-
diated keratinocytes (Schmitt et al, 2000b). Importantly,
UV-induced DNA damage has been reported to be the major
mediator by which UV induces the release of TNFa and IL-10
(Nishigori et al, 1996; Kibitel et al, 1998), and IL-12 might inhibit
UVB-induced apoptosis and DNA damage through induction of
nucleotide-excision repair enzymes (Schwarz et al, 2002). Putting
these results together, it is possible that IL-12 blocks UVB-in-
duced release of TNFa and IL-10 through stimulation of DNA
repair. Consistent with this idea, direct induction of DNA repair
in vivo protects skin fromUV-induced upregulation of both IL-10
and TNFa (Wolf et al, 2000).
At the level of theTNFa gene itself, our promoter transfection
studies show a substantial e¡ect of IL-12 at the level of transcrip-
tion, via elements within the ¢rst 1173 bp of theTNFa promoter.
The greater IL-12 sensitivity of the ^308A promoter variant rela-
tive to ^308G suggests that IL-12 may alter a transcription factor
that binds either uniquely or more avidly to one of the poly-
morphic alleles. Nevertheless, the precise molecular steps linking
Figure 2. UVA and UVB induce IL-12 release from human kerati-
nocytes. Keratinocytes were irradiated with UVA (5, 10, and 20 J per cm2)
or UVB (10, 20, and 30 mJ per cm2), followed by 24 h of incubation at
371C. Displayed are IL-12 concentrations in the conditioned media.
Figure 3. Anti-IL-12 antibodies increase TNFa production from
UVB-irradiated cells (a) Anti-IL-12 antibodies increase TNFa release
from UVB-irradiated adult keratinocytes. Adult keratinocytes were
irradiated with 30 mJ per cm2 of UVB, 5 J per cm2 of UVA, or sham irra-
diated, and then given media without (minus symbols) or with (plus symbols)
10 mg anti-IL-12 antibody per ml followed by 24 h of incubation at 371C.
Displayed are TNFa concentrations in the conditioned media. (b) Anti-IL-
12 antibodies increase TNFa release from UVB-irradiated ¢broblasts. Fi-
broblasts were irradiated with 30 mJ per cm2 of UVB, or sham irradiated,
and then given media without (minus symbols) or with (plus symbols) 10 ng
IL-1a per ml, 10 mg anti-IL-12 antibody per ml followed by 24 h of incu-
bation at 371C. Displayed are TNFa concentrations in the conditioned
media.
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UV irradiation and DNA damage to altered TNFa promoter ac-
tivity are not known.
This inhibitory e¡ect of IL-12 on keratinocytes and ¢broblasts,
which are nonimmune cells, contrasts with its e¡ect on immune
cells, where IL-12 is stimulatory or neutral on TNFa output
(Adorini, 1999; Xing et al, 2000). Prior work has shown that IL-
12 shifts in£ammatory cells fromTh2 toTh1 (Adorini, 1999), and
that IL-12 is required to maintain Th1 responses (Stobie et al,
2000).Thus, incorporating our results, IL-12 shifts the overall pat-
tern of TNFa output away from nonimmune cells such as kera-
tinocytes and ¢broblasts and speci¢cally towards Th1 immune
cells. This shift could serve important global regulatory roles,
such as decreasing TNFa-mediated apoptosis of keratinocytes,
thereby diminishing one source of self-antigen and enhancing
immune responses against exogenous infections.
As summarized before, several photosensitive diseases have
been associated with the ^308A TNFa promoter variant, and
studies in vitro show a substantially enhanced response of this
promoter variant to UVB (Werth et al, 2000). Nevertheless, many
patients with each of these diseases do not carry the ^308A poly-
morphism, suggesting that other regulatory factors could be
involved. Based on our ¢ndings, such factors could include
IL-10 polymorphisms and genetic variants of factors that are
known to regulate IL-12 or responses to IL-12.
From the standpoint of pathogenesis and therapeutics of
photosensitive diseases, an important di¡erence between UVB
and UVA at these doses is that UVB increased the secretion of
both TNFa (Fig 1a, b) and IL-12 (Fig 2), whereas UVA stimu-
lated secretion of only IL-12 (Fig 2) without increasing TNFa
(Fig 1a). Because we have now found that IL-12, both in physio-
logic and supraphysiologic doses, inhibits TNFa secretion from
nonimmune cells, it is likely that UVA or direct administration
of IL-12 could lessen or eliminate some of the TNFa-mediated
e¡ects of UVB. This model provides an attractive explanation
for the prior ¢nding that prior irradiation with UVA can blunt
the ability of UVB to inhibit contact hypersensitivities in mice
(Reeve et al, 1998); this e¡ect of UVB is mediated by TNFa
(Bromberg et al, 1992; Yoshikawa et al, 1992). In addition, a few
Figure 4. IL-12 has no e¡ect on IL-1a-mediated increase of collage-
nase. Quantitative comparison of collagenase message levels. RNAwas ex-
tracted from cultured control ¢broblast monolayers (lane 1) 24 h after IL-1a
(lanes 2^4),7IL-12 (500 pg per ml) (lane 3),7anti-TNFa antibody (lane 4),
and analyzed by northern blot. The ¢lters were hybridized sequentially
with a collagenase cDNA probe and then rehybridized with the 18S probe.
Figure 5. IL-12 inhibits the ^308A and ^308G TNFapromoter. Rela-
tive activities of TNFa^308G/b-gal construct following transfection into
cells. Cells were irradiated with 30 mJ per cm2 of UVB or sham irradiated,
and then given media without (minus symbols) or with (plus symbols) 10 ng
IL-12 per ml, 10 ng IL-1a per ml (for 3T3 cells only), followed by 24 h of
incubation at 371C. Displayed are normalized levels of CAT expressed by
theTNFa promoter construct. The bars represent means (7SEM) of tripli-
cate transfections. (a) Human adult keratinocytes transfected with ^308A
and ^308G TNFa promoter. (b) 3T3 cells transfected with ^308G TNFa
promoter. (c) 3T3 cells transfected with ^308ATNFa promoter.
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studies have suggested that UVA is therapeutic for some patients
with lupus erythematosus, particularly photosensitive forms such
as subacute cutaneous lupus erythematosus (McGrath, 1994); our
results imply that IL-12 might be helpful as well. Conversely, in
situations where IL-12 has been found to be therapeutic, such as
cutaneousTcell lymphoma or enhancement of vaccine responses,
selective UVA therapy might also provide a bene¢t.
We have found that IL-12 suppresses TNFa production by ker-
atinocytes and ¢broblasts. Because TNFa is involved in the
pathogenesis of certain photosensitive skin diseases (Werth et al,
2000), IL-12 and stimuli, such as UVA, that speci¢cally increase
IL-12 could play important physiologic, pathophysiologic, and
therapeutic roles.
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